China Resources Medical Holdings Company Limited (1PH) — Strategic Asset Allocation Index
China Resources Medical Holdings Company Limited (1PH) has a Strategic Asset Allocation Index of 75.6% as of June 2023. Strategic assets (PP&E of €5.43 Billion plus long-term investments of €-) total €5.43 Billion, measured against net assets of €7.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check China Resources Medical Holdings Company asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
China Resources Medical Holdings Company Limited Strategic Asset Allocation Index (2016–2022)
This chart shows how China Resources Medical Holdings Company Limited's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 75.6%, representing strategic assets of €5.43 Billion against net assets of €7.18 Billion EUR. See China Resources Medical Holdings Company financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for China Resources Medical Holdings Company Limited (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for China Resources Medical Holdings Company Limited from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is China Resources Medical Holdings Company worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 32.7% | €2.29 Billion | €2.29 Billion | €- | €7.00 Billion | ▲ +1.8 pp |
| 2021 | 30.9% | €2.12 Billion | €2.12 Billion | €- | €6.85 Billion | ▲ +14.5 pp |
| 2020 | 16.5% | €1.05 Billion | €1.05 Billion | €- | €6.34 Billion | ▲ +11.0 pp |
| 2019 | 5.5% | €337.43 Million | €337.43 Million | €- | €6.14 Billion | ▲ +1.0 pp |
| 2018 | 4.5% | €259.36 Million | €259.36 Million | €- | €5.71 Billion | ▼ 0.0 pp |
| 2017 | 4.6% | €256.60 Million | €256.60 Million | €- | €5.60 Billion | ▼ -0.4 pp |
| 2016 | 4.9% | €264.29 Million | €264.29 Million | €- | €5.36 Billion | — |